Elaine Paul has risen to the top of a predominantly male financial industry as the CFO of Hulu. She sits down with Alyssa Julya Smith in Los Angeles to talk about her impressive career. Prior to heading up a 100 person team at Hulu, Paul served as Senior Vice President of Corporate Strategy at the Walt Disney Company, where she led various acquisitions, new business initiatives, and strategic investments, including Disney’s original investment in Hulu in 2009. Paul also discusses the network's dedication to creating female empowering content like "The Handmaid's Tale" and what goes into the financial decisions behind what type of content to invest in as a company. Finally, as a female executive she speaks passionately about creating a good balance in her life, both for herself and other women who are struggling with "doing it all."

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More